The world’s first personalised mRNA cancer vaccine for melanoma halves the risk of patients dying or the disease.
Melanoma affects more than 150,000 people a year globally, according to 2020 figures from World Cancer Research Fund International.
Kingston Mills is a Professor of Experimental Immunology and Biochemistry at Trinity College Dublin and joins Seán to discuss.
